MADISON KENDRICK: Open Payments
NPI 1033700885 · DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,031 in 36 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,491 · 2025 $1,031
Food & beverage: $1,031
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 4 | $201 |
| Regeneron Healthcare Solutions, Inc. | 5 | $186 |
| AstraZeneca Pharmaceuticals LP | 6 | $142 |
| GlaxoSmithKline, LLC. | 5 | $107 |
| GENZYME CORPORATION | 4 | $95 |
| ABBVIE INC. | 2 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Mallinckrodt Hospital Products Inc. | 2 | $41 |
| Verona Pharma, Inc. | 2 | $41 |
| Baxter Healthcare | 1 | $34 |
Products named: DUPIXENT, UPTRAVI, FASENRA, TRELEGY ELLIPTA, GLASSIA, BREZTRI, OPSUMIT, NUCALA.
Industry payments across MA — which companies pay providers there.
